AI Medical Technology Doubles Down On Melanoma With Trials And Financing

Over the past month, the company has released positive clinical trial results and raised more cash, both of which will help on its way to combat melanoma.

Is it a mole? Or is it skin cancer? AI Medical Technology's Dermalyser aims to give doctors more confidence when making decisions either way. • Source: Shutterstock

2023 might just be the toughest year yet for medtech startups.

More from Clinical Trials

More from R&D